PRESS RELEASE published on 08/04/2025 at 09:50, 1 year 1 month ago Birgit Seeger appointed CEO of NORMA Group Birgit Seeger appointed as CEO of NORMA Group, effective November 1, 2025, bringing industry expertise and transformation experience. Seeger to lead with a focus on sustainable growth Sustainable Growth Transformation CEO NORMA Group Birgit Seeger
BRIEF published on 08/04/2025 at 09:45, 1 year 1 month ago Birgit Seeger Named CEO of NORMA Group SE CEO Appointment Supervisory Board NORMA Group SE Birgit Seeger Mark Wilhelms
BRIEF published on 08/04/2025 at 09:45, 1 year 1 month ago Birgit Seeger nommée PDG de NORMA Group SE Conseil De Surveillance Nomination Du PDG Birgit Seeger Groupe NORMA SE Marc Wilhelms
PRESS RELEASE published on 08/04/2025 at 09:40, 1 year 1 month ago EQS-Adhoc: NORMA Group SE: Birgit Seeger appointed as CEO of NORMA Group SE Birgit Seeger appointed as CEO of NORMA Group SE. Supervisory Board's decision for a 3-year term starting from November 1, 2025 CEO Appointment Supervisory Board Management Change NORMA Group SE Birgit Seeger
BRIEF published on 06/17/2025 at 09:19, 1 year 2 months ago NORMA Group Extends Dr. Daniel Heymann's Role as COO Operational Strategy NORMA Group Industrial Supplier Daniel Heymann COO Extension
BRIEF published on 06/17/2025 at 09:19, 1 year 2 months ago Le groupe NORMA prolonge le mandat du Dr Daniel Heymann au poste de directeur de l'exploitation Stratégie Opérationnelle Groupe NORMA Daniel Heymann Extension Du COO Fournisseur Industriel
PRESS RELEASE published on 06/17/2025 at 09:14, 1 year 2 months ago NORMA Group confirms Daniel Heymann as COO for a further three years NORMA Group extends COO contract with Dr. Daniel Heymann for three more years. Supervisory Board highlights his global industrial expertise and role in company's transformation Contract Extension COO Efficiency Improvements NORMA Group Global Industrial
BRIEF published on 05/06/2025 at 07:32, 1 year 4 months ago NORMA Group Faces Challenging Market Conditions in Early 2025 Market Environment Sales Decline Transformation NORMA Group Q1 2025
BRIEF published on 05/06/2025 at 07:32, 1 year 4 months ago Le groupe NORMA fait face à des conditions de marché difficiles début 2025 Transformation Baisse Des Ventes Groupe NORMA Environnement Du Marché T1 2025
PRESS RELEASE published on 05/06/2025 at 07:27, 1 year 4 months ago Difficult market environment impacts NORMA Group in first quarter of 2025 NORMA Group SE faces challenging market conditions with a 7.9% decrease in sales and 59.9% decline in adjusted EBIT in Q1 2025. The company initiates transformation into a focused industrial supplier Market Conditions Adjusted EBIT Sales Decrease NORMA Group SE Industrial Supplier
Published on 09/12/2026 at 02:35, 1 day 7 hours ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 1 day 10 hours ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 21:25, 1 day 12 hours ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 1 day 16 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 17:50, 16 hours 7 minutes ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 1 day 2 hours ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 1 day 11 hours ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 1 day 11 hours ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 1 day 14 hours ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 07:00, 2 days 2 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 2 days 2 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 2 days 14 hours ago Availability of the 2026 Interim Financial Report
